症状性颅内动脉粥样硬化性狭窄支架内再狭窄预测的斑块特征:一项回顾性单中心研究
该回顾性单中心研究纳入2018年3月至2024年6月接受HR-VWI及血管内治疗的217例症状性ICAD患者,评估斑块特征对支架内再狭窄(ISR)的预测价值。斑块偏心性、高斑块-垂体柄对比度比及低淋巴细胞/单核细胞比值是ISR独立预测因素,模型建模组AUC为0.783,验证组AUC为0.827。作者认为这些单中心发现可能有助于优化治疗策略,但需进一步验证。
要点
- 斑块偏心性是ISR的强独立预测因素(OR 32.661)。
- 高斑块-垂体柄对比度比与低淋巴细胞/单核细胞比值亦独立预测ISR。
- 列线图预测ISR的敏感度为75%、特异度为82.6%。
核心结论
- 在症状性ICAD患者中,ISR与斑块偏心性、HR-VWI上 elevated CR 及降低的淋巴细胞/单核细胞比值相关;这些单中心发现可能优化治疗策略并降低再狭窄风险,但需进一步验证以确认其普遍性与可靠性。
研究设计与样本
- 回顾性单中心研究,连续纳入2018年3月至2024年6月接受HR-VWI和血管内治疗的ICAD患者217例(平均年龄64.5±10.2岁;73.2%男性)。
诊断标准与关键数值
- ISR定义为支架内或支架附近(<5 mm)狭窄>50%且绝对管腔丢失>20%。
- 斑块偏心性预测ISR的OR为32.661(95%CI:3.726-286.334;p=0.002)。
- 斑块-垂体柄对比度比升高预测ISR的OR为2.702(95%CI:1.098-6.649;p=0.03)。
- 淋巴细胞/单核细胞比值降低预测ISR的OR为0.251(95%CI:0.106-0.594;p=0.002)。
- 模型建模组AUC为0.783(95%CI:0.683-0.883),验证组AUC为0.827(95%CI:0.717-0.936),cutoff为0.3;列线图敏感度75%、特异度82.6%。
临床应用与阅片要点
- 术前HR-VWI评估斑块偏心性及斑块-垂体柄对比度比可能有助于ISR风险分层。
- 结合淋巴细胞/单核细胞比值可进一步提升预测能力。
- 作者认为术前ISR预测可能实现个体化策略(如支架优化、靶向抗炎治疗),可能降低再狭窄及卒中复发风险。
局限性
- 原文为回顾性单中心研究。
- 原文结论指出需进一步验证以确认发现的普遍性与可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This retrospective single-center study evaluates whether high-resolution magnetic resonance vessel wall imaging (HR-VWI) plaque features can predict in-stent restenosis (ISR) before stent implantation.
MATERIALS AND METHODS: Consecutive intracranial atherosclerotic disease (ICAD) patients undergoing HR-VWI and endovascular treatment from March 2018 to June 2024 were analyzed. ISR was defined as > 50% stenosis within or near (< 5 mm) the stent and > 20% absolute luminal loss. Multivariate logistic regression identified independent ISR risk factors, developing a prediction model and diagnostic nomogram. ISR-free survival was evaluated using Kaplan-Meier curves.
RESULTS: Among 217 patients (mean age 64.5 ± 10.2 years; 73.2% male), 50 (23.0%) developed ISR within 1 year. Plaque eccentricity (odds ratio (OR), 32.661; 95% confidence interval (CI): 3.726-286.334; p = 0.002), higher plaque-to-pituitary stalk contrast ratio (CR) (OR, 2.702; 95% CI: 1.098-6.649; p = 0.03), and lower lymphocyte-to-monocyte ratio (OR, 0.251; 95% CI: 0.106-0.594; p = 0.002) were independent ISR predictors. The model's AUC was 0.783 (95% CI: 0.683-0.883) for modeling and 0.827 (95% CI: 0.717-0.936) for validation, with a 0.3 cutoff. Kaplan-Meier analysis showed higher 12-month restenosis-free rates for patients with plaque eccentricity < 0.57 (68.5% vs. 27.7%; p < 0.001), CR < 38.22 (76.6% vs. 34.4%; p < 0.001) and lymphocyte-to-monocyte ratio ≥ 3.27 (70.4% vs. 37.6%; p < 0.001).
CONCLUSIONS: In symptomatic ICAD patients, ISR was linked to plaque eccentricity, elevated CR on HR-VWI, and reduced lymphocyte-to-monocyte ratio. These single-center findings may optimize therapeutic strategies and reduce restenosis risk, though further validation is needed to confirm their generalizability and reliability.
KEY POINTS: Question Can clinical and imaging biomarkers predict in-stent restenosis (ISR) in symptomatic intracranial atherosclerotic stenosis (ICAD) to guide preprocedural risk stratification? Findings Plaque eccentricity, high plaque-to-pituitary stalk contrast ratio, and low lymphocyte-to-monocyte ratio independently predict ISR; our nomogram achieved 75% sensitivity and 82.6% specificity. Clinical relevance Preprocedural ISR prediction enables personalized strategies (e.g., stent optimization, targeted anti-inflammatory therapy), potentially reducing restenosis and stroke recurrence risk in ICAD patients undergoing stenting.
引用
- Hu T, Ling R, Xue X, et al. Plaque features for the prediction of in-stent restenosis in symptomatic intracranial atherosclerotic stenosis from a retrospective single-center study. Eur Radiol. 2025. PMID: 41269300. doi:10.1007/s00330-025-11964-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。